These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32502586)

  • 21. Visualisation of penetration of topical antifungal drug substances through mycosis-infected nails by matrix-assisted laser desorption ionisation mass spectrometry imaging.
    Endringer Pinto F; Bagger C; Kunze G; Joly-Tonetti N; Thénot JP; Osman-Ponchet H; Janfelt C
    Mycoses; 2020 Aug; 63(8):869-875. PubMed ID: 32406142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral antifungal medication for toenail onychomycosis.
    Kreijkamp-Kaspers S; Hawke K; Guo L; Kerin G; Bell-Syer SE; Magin P; Bell-Syer SV; van Driel ML
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010031. PubMed ID: 28707751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Timeline of Onychomycosis Therapy and Future Directions.
    Geizhals S; Lipner SR
    Skinmed; 2020; 18(6):367-371. PubMed ID: 33397567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis.
    Tosti A
    Cutis; 2013 Oct; 92(4):203-8. PubMed ID: 24195094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical therapy for toenail onychomycosis: an evidence-based review.
    Gupta AK; Daigle D; Foley KA
    Am J Clin Dermatol; 2014 Dec; 15(6):489-502. PubMed ID: 25257931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
    Pollak RA
    J Am Podiatr Med Assoc; 2014 Nov; 104(6):568-73. PubMed ID: 25514267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
    Baran R; Kaoukhov A
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):21-9. PubMed ID: 15649187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration.
    Wang Y; Lipner SR
    Arch Dermatol Res; 2020 Oct; 312(8):581-586. PubMed ID: 32076805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Onychomycosis in the elderly.
    Gupta AK
    Drugs Aging; 2000 Jun; 16(6):397-407. PubMed ID: 10939306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.
    Del Rosso JQ
    J Clin Aesthet Dermatol; 2014 Jul; 7(7):10-8. PubMed ID: 25053979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis.
    Bunyaratavej S; Leeyaphan C; Rujitharanawong C; Surawan TM; Muanprasat C; Matthapan L
    J Dermatolog Treat; 2016 Aug; 27(4):359-63. PubMed ID: 26471716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JUBLIA (Efinaconazole 10% Solution) in the Treatment of Pediatric Onychomycosis.
    Gupta AK; Venkataraman M; Abramovits W; Guenin EP
    Skinmed; 2021; 19(3):206-210. PubMed ID: 34303391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal agents for onychomycosis: new treatment strategies to improve safety.
    Zane LT; Chanda S; Coronado D; Del Rosso J
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Onychomycosis in children: a brief overview with treatment strategies.
    Gupta AK; Skinner AR
    Pediatr Dermatol; 2004; 21(1):74-9. PubMed ID: 14871333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
    Gupta AK; Fleckman P; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
    Feng X; Xiong X; Ran Y
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28097731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
    McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
    Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and economic factors in the treatment of onychomycosis.
    Einarson TR; Gupta AK; Shear NH; Arikian S
    Pharmacoeconomics; 1996 Apr; 9(4):307-20. PubMed ID: 10160105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onychomycosis due to Neoscytalidium treated with oral terbinafine, ciclopirox nail lacquer and nail abrasion: a pilot study of 25 patients.
    Cursi ÍB; Silva RT; Succi IB; Bernardes-Engemann AR; Orofino-Costa R
    Mycopathologia; 2013 Feb; 175(1-2):75-82. PubMed ID: 22976905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.